Relationship between disease activity and type 1 interferon- and other cytokine-inducible gene expression in blood in dermatomyositis and polymyositis-Reference-Cited by-同舟云学术

Relationship between disease activity and type 1 interferon- and other cytokine-inducible gene expression in blood in dermatomyositis and polymyositis

Published:2011-09-01 Issue:3 Volume:13 Page:207-213
ISSN:1466-4879
Container-title:Genes & Immunity
language:en
Short-container-title:Genes Immun

Author:

Greenberg S A,Higgs B W,Morehouse C,Walsh R J,Won Kong S,Brohawn P,Zhu W,Amato A,Salajegheh M,White B,Kiener P A,Jallal B,Yao Y

Publisher

Springer Science and Business Media LLC

Subject

Genetics (clinical),Genetics,Immunology

Link

http://www.nature.com/articles/gene201161.pdf

Reference38 articles.

1. Mastaglia FL, Garlepp MJ, Phillips BA, Zilko PJ . Inflammatory myopathies: clinical, diagnostic and therapeutic aspects. Muscle Nerve 2003; 27: 407–425.

2. Christopher-Stine L, Plotz PH . Adult inflammatory myopathies. Best Pract Res Clin Rheumatol 2004; 18: 331–344.

3. Hoogendijk JE, Amato AA, Lecky BR, Choy EH, Lundberg IE, Rose MR et al. 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10–12 October 2003, Naarden, The Netherlands. Neuromuscul Disord 2004; 14: 337–345.

4. Amato AA, Griggs RC . Treatment of idiopathic inflammatory myopathies. Curr Opin Neurol 2003; 16: 569–575.

5. Choy EH, Hoogendijk JE, Lecky B, Winer JB, Gordon P . Withdrawn: immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis. Cochrane Database Syst Rev 2009; 4: CD003643.

Cited by 116 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Type 2 hypersensitivity disorders, including systemic lupus erythematosus, Sjögren’s syndrome, Graves’ disease, myasthenia gravis, immune thrombocytopenia, autoimmune haemolytic anaemia, dermatomyositis, and graft-versus-host disease, are THαβ-dominant autoimmune diseases;Virulence;2024-09-12

2. Innovation in Dermatomyositis;Dermatologic Clinics;2024-09

3. Role of Galectin-9, CXCL-10, APRIL, TNFRII and BAFF as Biomarkers in Idiopathic Inflammatory Myopathy: A Longitudinal Cohort Study;Indian Journal of Rheumatology;2024-08-29

4. Personalised medicine in juvenile dermatomyositis: From novel insights in disease mechanisms to changes in clinical practice;Best Practice & Research Clinical Rheumatology;2024-08

5. JAK inhibitors in refractory juvenile rheumatic diseases: Efficacy, tolerance and type-I interferon profiling, a single center retrospective study;Journal of Autoimmunity;2024-07